Selected article for: "activity induction and acute infection"

Title: Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice
  • Document date: 1981_10_1
  • ID: v1r0idg0_27
    Snippet: The in vitro induction of procoagulant activity (PCA) in murine peripheral blood mononuclear cells (PBM) by murine hepatitis virus type 3 (MHV-3) correlates with the disease susceptibility in three strains of mice. PBM from BALB/c mice, a strain in which MHV-3 infection results in fatal acute fulminant hepatitis, responds to the virus with a robust PCA response, whereas PBM from C3H/St mice, a strain which develops mild acute hepatitis followed b.....
    Document: The in vitro induction of procoagulant activity (PCA) in murine peripheral blood mononuclear cells (PBM) by murine hepatitis virus type 3 (MHV-3) correlates with the disease susceptibility in three strains of mice. PBM from BALB/c mice, a strain in which MHV-3 infection results in fatal acute fulminant hepatitis, responds to the virus with a robust PCA response, whereas PBM from C3H/St mice, a strain which develops mild acute hepatitis followed by chronic hepatitis, only exhibit a modest PCA response. In contrast, PBM from A/J mice, a strain fully resistant to MHV-3, generate no increase in PCA above control levels. The induction phase of MHV-3 PCA is rapid, with an increase within 1-1.5 h, with maximum activity at 18 h, and it precedes MHV-3 replication in either 17 CL1 cells, a fully permissive cell line, or in monocytes from these strains of mice. The PCA response of BALB/c PBM exceeds the response to any other known stimulus. No induction occurs upon direct stimulation of monocytes by MHV-3, but in the presence of lymphocyte collaboration, the PCA response is observed first at a lymphocyte:monocyte ratio of 2:1 and reaches a maximum as the lymphocyte:monocyte ratio approaches 4:1.

    Search related documents:
    Co phrase search for related documents
    • acute hepatitis and blood mononuclear cell: 1
    • acute hepatitis and cell line: 1, 2, 3, 4, 5, 6, 7, 8
    • acute hepatitis and chronic hepatitis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute hepatitis and chronic hepatitis follow: 1, 2
    • acute hepatitis and CL1 cell: 1
    • acute hepatitis and direct stimulation: 1
    • acute hepatitis and disease susceptibility: 1, 2, 3
    • acute hepatitis and fatal acute fulminant hepatitis: 1
    • acute hepatitis and fully permissive cell line: 1
    • acute hepatitis and fully resistant strain: 1
    • acute hepatitis and fulminant hepatitis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute hepatitis and hepatitis virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • blood mononuclear and direct stimulation: 1, 2
    • blood mononuclear and disease susceptibility: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • blood mononuclear and fatal acute fulminant hepatitis: 1
    • blood mononuclear and fully permissive cell line: 1
    • blood mononuclear and fully resistant strain: 1
    • blood mononuclear and fulminant hepatitis: 1, 2
    • blood mononuclear and hepatitis virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14